Next-generation targeted cytokine therapy to be explored on advancements series

  • Post published:February 27, 2020

JUPITER, Fla., Feb. 27, 2020 /PRNewswire-PRWeb/ — An upcoming episode of Advancements with Ted Danson, scheduled to broadcast Q4/2020, will explore innovative treatment solutions for maladies, such as Inflammatory Bowel Disease (IBD), specifically Crohn’s Disease (Crohn’s), and Oncology. Check local listings for more info.

This segment will focus on a novel platform developed by Deka Biosciences, Inc. (Deka Biosciences), that will enable the delivery of next generation cytokine or combination of cytokines to a specific tissue of interest. Viewers will learn how this cutting-edge technology, termed Diakines™, has led to the development of two potential therapeutic molecules involving an affinity modified Interleukin 10 cytokine.

Watch the segment here.